Mixed Hormone Receptor (ER+/PR- Or ER-/PR+) Breast Cancer Prognosis

Mixed Hormone Receptor (ER+/PR- Or ER-/PR+) Breast Cancer Prognosis

4.5
(315)
Write Review
More
$ 15.00
Add to Cart
In stock
Description

Detailed information on mixed hormone receptor (ER+/PR- or ER-/PR+) breast cancer prognosis, based on the latest scientific studies.

Breast Cancer: Practice Essentials, Background, Anatomy

Frontiers Prognostic Relevance of Estrogen Receptor Status in

The Clinical and Biological Significance of Estrogen Receptor-Low

Ductal Carcinoma In Situ (DCIS)

ER+/PR+ Breast Cancer Characteristics

Estrogen receptor-negative/progesterone receptor-positive and her

The challenges of modeling hormone receptor-positive breast cancer

Silencing growth hormone receptor inhibits estrogen receptor

Frontiers Clinical implication of low estrogen receptor (ER-low